Approximately 30% of cancer patients respond to ICB therapy, some for very extended periods. ICB is an enormous step forwar for many cancers such as melanoma but still, the majority of patients do not respond or relapse after initial response. The discussion on this topi is hot and there is evidence for different causes of resistance. I would like to know your experience.
Hi Ulrich, I would like to introduce you to the work of my colleague, Dan Adams, who is isolating giant cells from patient blood samples.
These cells bear the hallmark of both macrophages and megakaryocytes and are probably the tumor associated macrophages (giant cells) that pathologists described in biopsies decades ago.
They could be the missing link in the interactions of the immune system with cancer cells.
Daniel Lee Adams
- Badges
- Science topic
- Similar topics
- Entomology
- Resistance